Patrik Vitazka
- Oncology top 5%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Genetics top 10%
- Epidemiology
- Co-authors
- Naiyer A. RizviAkin AtmacaMatthew D. HellmannFred R. HirschPaolo A. AsciertoGiovanni SelvaggiAriella SassonChang Han
- Topics
- Cancer Genomics and Diagnostics (5 papers)Genomics and Rare Diseases (4 papers)RNA modifications and cancer (3 papers)
- Cited by
- OncologyCancer ResearchGenetics
- Partner nations
- United StatesSpainQatar
In The Last Decade
Patrik Vitazka
13 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Oncology 636
- Molecular Biology 399
- Pulmonary and Respiratory Medicine 243
- Genetics 217
- Epidemiology 213
Countries citing papers authored by Patrik Vitazka
This map shows the geographic impact of Patrik Vitazka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrik Vitazka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrik Vitazka more than expected).
Fields of papers citing papers by Patrik Vitazka
This network shows the impact of papers produced by Patrik Vitazka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrik Vitazka. The network helps show where Patrik Vitazka may publish in the future.
Co-authorship network of co-authors of Patrik Vitazka
This figure shows the co-authorship network connecting the top 25 collaborators of Patrik Vitazka. A scholar is included among the top collaborators of Patrik Vitazka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrik Vitazka. Patrik Vitazka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 17 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancerbreakdown → | 670 |
| 6 | 0 | |
| 7 | 42 | |
| 8 | 140 | |
| 9 | 44 | |
| 10 | 39 | |
| 11 | 43 | |
| 12 | 34 | |
| 13 | 8 | |
| 14 | 107 |
About Patrik Vitazka
Patrik Vitazka is a scholar working on Cancer Research, Genetics and Oncology, having authored 14 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (5 papers), Genomics and Rare Diseases (4 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Oncology (636 citations), Cancer Research (192 citations) and Genetics (217 citations). Patrik Vitazka has collaborated with scholars based in United States, Spain and Qatar. Frequent co-authors include Naiyer A. Rizvi, Akin Atmaca, Matthew D. Hellmann, Fred R. Hirsch, Paolo A. Ascierto, Giovanni Selvaggi, Ariella Sasson, Chang Han, Margaret K. Callahan and Scott Antonia. Their work appears in journals such as Journal of Clinical Oncology, Blood and Journal of Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.